Lexaria Bioscience (LEXX) Shares Outstanding (2011 - 2026)

Lexaria Bioscience has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $12.5 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 42.24% year-over-year to $12.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $12.5 million (up 42.24% YoY) and the FY2025 annual result came in at $8.8 million, up 27.72% from the prior year.
• Shares Outstanding (Entity) declined to $12.5 million in Q2 2026 per LEXX's latest filing, from $12.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $15.8 million in Q2 2024 and troughed at $4.0 million in Q4 2024.
• A 5-year average of $8.6 million and a median of $7.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) sank 61.56% in 2024, then soared 191.18% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $6.0 million in 2022, then jumped by 73.28% to $10.3 million in 2023, then tumbled by 61.56% to $4.0 million in 2024, then jumped by 191.18% to $11.5 million in 2025, then rose by 8.23% to $12.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $12.5 million, $12.6 million, and $11.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.